Investors have seemingly homed in on flat sales in the Watchman and electrophysiology segments of Boston’s cardio portfolio, ...

By Kamal Choudhury Feb 4 (Reuters) - Boston Scientific on Wednesday reported lower-than-expected quarterly sales in its key electrophysiology division, dragging the medical device maker's shares as ...

Boston Scientific Corporation (NYSE:BSX) Q4 2025 Earnings Call Transcript February 4, 2026 Boston Scientific Corporation ...

Pulsed field ablation has fueled strong sales growth for the firm’s electrophysiology business over the past two years.

Shasta Regional Medical Center is celebrating the beginning of American Heart Month by reminding the public of their ...

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational1 basis and ...

Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of ...

A 2025 study found that coffee drinkers may have a 40% lower risk of AFib recurrence. More research from 2025 shows that drinking black coffee daily can lower a person’s overall mortality risk and ...

Medtronic (NYSE:MDT) reported new positive post-market clinical evidence for its Penditure left atrial appendage (LAA) ...

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025 ...